OBJECTIVE To describe disease recurrence in polymyalgia rheumatica. METHODS I present 12 patients with recurring PMR from a single clinical practice with long-term clinical follow-up (mean 14.3 years). RESULTS Despite a disease-free interval off corticosteroids of 2 years or longer, these patients experienced 1 overt recurrence (or more) of PMR. CONCLUSION The course of PMR is not uniform...

We read with interest the excellent article “Giant cell arteritis” by Smith and Swanson. The authors note several factors that have putative roles in the pathogenesis of giant cell arteritis (GCA). In this regard, we would like to mention an additional point. Recently, several cases of polymyalgia rheumatica/GCA occurring in patients who received ipilimumab were reported. Ipilimumab is an immun...